Sunday, March 16, 2025 | 06:21 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Centre keen on testing Gilead's remdesivir to combat coronavirus

The USFDA has recently given an emergency approval to the drug for use on coronavirus patients

The government is now trying to understand how long it will take before the drug’s production can start in India
Premium

The government is now trying to understand how long it will take before the drug’s production can start in India

Sohini Das Mumbai
As trials on anti-viral drugs pick up, the Centre has now turned its focus on ensuring that remdesivir, Gilead's repurposed Ebola drug, is available for trials here. The USFDA has recently given an emergency approval to the drug for use on coronavirus patients.

This has generated interest among the authorities, who want to conduct trials on patients here. “Our clinicians can use remdesivir on patients here on compassionate grounds. However, the drug needs to be available. It is a patented drug and we understand it is complex to make as well,” said a senior government official.

He added that the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in